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During recent years, but particularly since 2015, con-
cern on Zika virus has grown for multiple reasons, such 
as its association with the occurrence of Guillain–Barré 
syndrome and microcephaly [1, 2]. Nevertheless, in addi-
tion to all epidemiological implications of the outbreak 
in Latin America [3] the number of affected cases con-
tinue to rise and expected to reach over four million in 
2016, adding to this the possibility of new modes of 
transmission.
Zika virus is a zoonotic pathogen, naturally and experi-
mentally hosted in non-human primates [4] as well as 
experimentally in Swiss albino mices [5, 6]. Then, rhesus 
monkeys can be the source in natural habitats of human 
infections, through the bite of Aedes aegypti and A. 
albopictus (multiple other species and genus have been 
implicated) (Fig. 1), in infected monkeys and later trans-
mission to susceptible human hosts.
Zika virus is predominantly a vector-borne disease 
(Fig. 1), although after the epidemics in the Pacific region 
it was clear that transplacental and perinatal transmis-
sion [7, 8] could also occur. However, the associated 
risk of microcephaly has been identified and highlighted 
much more recently as evidences continue to be added in 
different studies (Fig. 1) [8, 9].
Before the current epidemics not a single study 
raised that relationship, and, right now a significant 
number of pregnant women and their newborns are 
being monitored in Brazil [9], Colombia and other 
countries in the region for central nervous system 
anomalies. Zika has been detected in newborns, pla-
centa and umbilical cords, as well in pregnant women 
by RT-PCR [8, 9]. There have been no reports detect-
ing viable and potentially infective virus in breast milk 
up to now.
In addition to mother-to-child transmission, during 
the last decade, cases of sexual transmission have been 
reported [10–12], representing a non-vector borne form 
of transmission of Zika virus (Fig. 1). Zika virus has been 
detected in human saliva [13], blood, semen and urine 
[14]. It has been recently detected in semen and urine 
of, respectively, a patient after 62  days of infection [15] 
and another patient after 14 days of infection [16]. Also 
spread of the virus through blood transfusion and organ 
transplantation have been reported or suspected [17]. 
Zika virus infections have been documented through lab-
oratory exposure [18].
Another emerging aspect of this zoonosis has been 
the possible transmission through bites of monkeys and 
other non-human primates (Fig.  1). This has also been 
recently reported [19].
Summarizing, Zika virus is primarily a vector-borne 
disease (mainly by A. aegypti), but there are also sec-
ondary modes of transmission (mother-to-child, sexual, 
blood transfusion, transplantation, non-human primate 
bites) (Fig.  1). This imply that prevention and control 
should consider all these ways of transmission, providing 
strategies to reduce new infections from this arbovirus 
that still need further basic, epidemiological and clini-
cal assessment in order to clarify and understand its real 
impact on human health. Zika represents a real challenge 
for the medical and scientific community as well as for 
the world [20].
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Fig. 1 Summary of reported forms of transmission of Zika virus
